Nepeta menthoides Boiss. & Buhse freeze-dried aqueous extract versus sertraline in the treatment of major depression: A double blind randomized controlled trial

Complementary Therapies in Medicine

Volumn 26, Issue , 2016, Pages 164-170

  Kolouri, Sepideh ^a,b   Firoozabadi, Ali ^c   Salehi, Alireza ^a,b   Zarshenas, Mohammad M ^d,e   Dastgheib, Seyed Ali ^b   Heydari, Mojtaba ^a,b   Rezaeizadeh, Hossein ^f  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^f TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Herbal medicine; Major depressive disorders; Nepeta menthoides; Persian traditional medicine

Indexed keywords

NEPETA MENTHOIDES EXTRACT; PLANT EXTRACT; SERTRALINE; UNCLASSIFIED DRUG; ANTIDEPRESSANT AGENT;

ADULT; AGED; ANTIDEPRESSANT ACTIVITY; ARTICLE; BECK DEPRESSION INVENTORY; BEDTIME DOSAGE; BLURRED VISION; CLINICAL ARTICLE; CONSTIPATION; CONTROLLED STUDY; DECREASED APPETITE; DOUBLE BLIND PROCEDURE; DROWSINESS; DRUG DOSE INCREASE; DRUG EFFICACY; DSM-5; FEMALE; FOLLOW UP; FREEZE DRYING; HEADACHE; HERB; HUMAN; HYPOACTIVE SEXUAL DESIRE DISORDER; INCREASED APPETITE; INSOMNIA; MAJOR DEPRESSION; MALE; MOOD; MORNING DOSAGE; NAUSEA; NEPETA MENTHOIDES; PARALLEL DESIGN; PATIENT SELECTION; PRURITUS; RANDOMIZED CONTROLLED TRIAL; RASH; RECURRENCE RISK; RESPIRATORY TRACT DISEASE; RESTLESSNESS; SIDE EFFECT; STRUCTURED INTERVIEW; TREATMENT DURATION; URINE RETENTION; VOMITING; XEROSTOMIA; DEPRESSIVE DISORDER, MAJOR; HISTORY OF MEDICINE; MIDDLE AGED; NEPETA; PATHOPHYSIOLOGY;

ADULT; ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER, MAJOR; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MEDICINE, ARABIC; MIDDLE AGED; NEPETA; PLANT EXTRACTS; SERTRALINE;

EID: 84963679528     PISSN: 09652299     EISSN: 18736963     Source Type: Journal    
DOI: 10.1016/j.ctim.2016.03.016     Document Type: Article

References (59)

1. Rashidkhani B., Gargari B.P., Ranjbar F., Zareiy S., Kargarnovin Z. Dietary patterns and anthropometric indices among Iranian women with major depressive disorder. Psychiatry Res 2013, 210:115-120.
2. Association A.P. DSM-5: Diagnostic and Statistical Manual of Mental Disorders 2013, American Psychiatry Publishing, Washington DC. 5th ed.
3. Sullivan P.F., Neale M.C., Kendler K.S. Genetic epidemiology of major depression: review and meta-analysis. Am J Psychiatry 2014.
4. Reddy M. Depression the disorder and the burden. Indian J Psychol Med 2010, 32:1.
5. Abolfazli R., Hosseini M., Ghanizadeh A., et al. Double-blind randomized parallel-group clinical trial of efficacy of the combination fluoxetine plus modafinil versus fluoxetine plus placebo in the treatment of major depression. Depress Anxiety 2011, 28:297-302.
6. Montazeri A., Mousavi S.J., Omidvari S., Tavousi M., Hashemi A., Rostami T. Depression in Iran: a systematic review of the literature (2000-2010). Payesh 2013.
7. Mayoclinicstaff. Depression (Major depressive disorders). 2015. http://www.Mayoclinic.org.
8. Saveanu R.V., Nemeroff C.B. Etiology of depression: genetic and environmental factors. Psychiatr Clin N Am 2012, 35:51-71.
9. Nikfarjam M., Parvin N., Assarzadegan N., Asghari S. The effects of Lavandula angustifolia mill infusion on depression in patients using citalopram: a comparison study. Iran Red Crescent Med J 2013, 15:734.
10. Firoozabadi A., Zarshenas M.M., Salehi A., Jahanbin S., Mohagheghzadeh A. Effectiveness of Cuscuta planiflora Ten. and Nepeta menthoides Boiss. & Buhse in major depression a triple-blind randomized controlled trial study. J Evid Based Complement Altern Med 2014, 2156587214557359.
11. Verrusio W., Andreozzi P., Marigliano B., et al. Exercise training and music therapy in elderly with depressive syndrome: a pilot study. Complement Ther Med 2014, 22:614-620.
12. Noorbala A., Tahmasebi-Pour N., Akhondzadeh S., Khani M., Jamshidi A. Crocus sativus L. in the treatment of milk to moderate depression: a double-blind, randomised and placebo controlled trial. J Med Plants 2004, 3.
13. Khawam E.A., Laurencic G., Malone D.A. Side effects of antidepressants: an overview. Clevel Clin J Med 2006, 73:351-353.
14. Labbate L.A.F.M., Rosenbaum J.F., Arana G.W. Drugs for the Treatment of Depression. Handbook of Psychiatric Drug Therapy 2010, Philadelphia Lippincott Williams & Wilkins, p. 54. 6th ed.
15. Zahajszky J., Rosenbaum J.F., Tollefson G.D. The American Psychiatric Publishing Textbook of Psychopharmacology 2009, American Psychiatric Pub.
16. Treatment Guidelines from The Medical Letter. The Medical Letter, 2010.
17. Mojtabai R., Olfson M. National patterns in antidepressant treatment by psychiatrists and general medical providers: results from the national comorbidity survey replication. J Clin Psychiatry 2008.
18. Mechael Hersch RJB. Selective serotonin reuptake inhibitors: pharmacology, administration and side effects. 2015. http://www.uptodate.com.
19. Cipriani A., La Ferla T., Furukawa T.A., et al. Sertraline versus other antidepressive agents for depression. Cochrane Database Syst Rev 2010, 4. CD006117.
20. Akhondzadeh S., Fallah-Pour H., Afkham K., Jamshidi A.-H., Khalighi-Cigaroudi F. Comparison of Crocus sativus L. and imipramine in the treatment of mild to moderate depression: a pilot double-blind randomized trial [ISRCTN45683816]. BMC Complement Altern Med 2004, 4:12.
21. Unützer J., Klap R., Sturm R., et al. Mental disorders and the use of alternative medicine: results from a national survey. Am J Psychiatry 2014.
22. Ren Y., Zhu C., Wu J., Zheng R., Cao H. Comparison between herbal medicine and fluoxetine for depression: a systematic review of randomized controlled trials. Complement Ther Med 2015, 23:674-684.
23. Beaubrun G., Gray G.E. A review of herbal medicines for psychiatric disorders. Psychiatr Serv 2014.
24. Hashempur M.H., Heydari M., Mosavat S.H., Heydari S.T., Shams M. Complementary and alternative medicine use in Iranian patients with diabetes mellitus. J Integr Med 2015, 13:319-325.
25. Panahi Y., Badeli R., Karami G.-R., Badeli Z., Sahebkar A. A randomized controlled trial of 6-week Chlorella vulgaris supplementation in patients with major depressive disorder. Complement Ther Med 2015, 23:598-602.
26. Nasri S., Gh A., Bidaran S. Anti-inflammatory and anti-nociceptive effects of hydroalcoholic extract of Nepeta menthoides on pain in aerial parts in male mice. J Jahrom Univ Med Sci 2013, 11.
27. Kahkeshani N., Razzaghirad Y., Ostad S.N., et al. Cytotoxic, acetylcholinesterase inhibitor and antioxidant activity of Nepeta menthoides Boiss & Buhse essential oil. J Essent Oil Bear Plants 2014, 17:544-552.
28. Rhazes M. Al-Havi. International Academy of Medical Sciences, Tehran, Iran (Original work published 10th century) [Arabic], 2005, p. 45.
29. Ahwazi A.M. Kamel al-Sanaah al-Tibbiyah (The Perfect Art of the Medicine). v.3 2008, Jalal-ed-Din Press, Tehran, p. 414 [Arabic].
30. Ibn-Sina A. Al-Qanon fi al-Tibb. V. 2 2005, Al-Aelami le-Al-Matbooat Institue, Lebanon, p. 363 [Arabic].
31. Formisano C., Rigano D., Senatore F. Chemical constituents and biological activities of Nepeta species. Chem Biodivers 2011, 8:1783-1818.
32. Ghassemzadeh H., Mojtabai R., Karamghadiri N., Ebrahimkhani N. Psychometric properties of a Persian-language version of the Beck depression inventory-second edition: bDI-II-PERSIAN. Depress Anxiety 2005, 21:185-192.
33. Aghili-Khorasani M, Makhzan-al-Adviyeh. Tehran: The Institute of Medical History Studies, Islamic and Complementary Medicine of The Iran University of Medical Sciences; 1387. P. 122-123 [Persian].
34. Ratajczak M., Kubicka M., Kamińska D., Sawicka P., Długaszewska J. Microbiological quality of non-sterile pharmaceutical products. Saudi Pharm J 2015, 23:303-307.
35. Singleton V.L., Orthofer R., Lamuela-Raventos R.M. Analysis of total phenols and other oxidation substrates and antioxidants by means of Folin-Ciocalteu reagent. Methods Enzymol 1999, 299:152-178.
36. Pourmorad F., Hosseinimehr S., Shahabimajd N. Antioxidant activity, phenol and flavonoid contents of some selected Iranian medicinal plants. Afr J Biotechnol 2006, 5.
37. Shrikumar S., Maheshwari U., Sughanti A., Ravi T. WHO Guidelines for Herbal Drug Standardization 2006, World Health Organization, Geneva.
38. Szegedi A., Jansen W.T., Van Willigenburg A., van der Meulen E., Stassen H.H., Thase M.E. Early improvement in the first 2 weeks as a predictor of treatment outcome in patients with major depressive disorder: a meta-analysis including 6562 patients. J Clin Psychiatry 2009, 70:344-353.
39. McIntyre R.S. When should you move beyond first-line therapy for depression?. J Clin Psychiatry 2010, 71(1). 1,478-20.
40. Wang Y.-P., Gorenstein C. Psychometric properties of the Beck depression inventory-II: a comprehensive review. Rev Bras Psiquiatr 2013, 35:416-431.
41. Akhondzadeh S. Herbal medicines in the treatment of psychiatric and neurological disorders. Low-Cost Approaches to Promote Physical and Mental Health 2007, Springer, p. 119-138.
42. Akhondzadeh S., Tahmacebi-Pour N., Noorbala A.A., et al. Crocus sativus L. in the treatment of mild to moderate depression: a double-blind, randomized and placebo-controlled trial. Phytother Res: PTR 2005, 19:148-151.
43. Basti A.A., Moshiri E., Noorbala A.-A., Jamshidi A.-H., Abbasi S.H., Akhondzadeh S. Comparison of petal of Crocus sativus L. and fluoxetine in the treatment of depressed outpatients: a pilot double-blind randomized trial. Prog NeuroPsychopharmacol Biol Psychiatry 2007, 31:439-442.
44. Bent S. Herbal medicine in the United States: review of efficacy, safety, and regulation. J Gen Intern Med 2008, 23:854-859.
45. Köhler O., Krogh J., Mors O., Benros M. Inflammation in depression and the potential for anti-inflammatory treatment. Current Neuropharmacol 2015.
46. Bozorgmehr F.M., M Faizi B. Evaluation of sedative-hypnotic effect of ethanolic extract of five medicinal plants; Nepeta menthoides, Matricaria chamomilla, Asperugo procumbens, Lippia citriodora and Withania somnifera. Res Pharm Sci 2012, 7:S831.
47. Abdelhalim A., Karim N., Chebib M., et al. Antidepressant, anxiolytic and antinociceptive activities of constituents from Rosmarinus officinalis. J Pharm Pharm Sci 2015, 18:448-459.
48. Dias G.P., Cavegn N., Nix A., et al. The role of dietary polyphenols on adult hippocampal neurogenesis: molecular mechanisms and behavioural effects on depression and anxiety. Oxid Med Cell Longevity 2012, 2012.
49. Messaoudi M., Bisson J.-F., Nejdi A., Rozan P., Javelot H. Antidepressant-like effects of a cocoa polyphenolic extract in Wistar-Unilever rats. Nutr Neurosci 2008, 11:269-276.
50. Gong J., Huang J., Ge Q., Chen F., Zhang Y. Advanced research on the antidepressant effect of flavonoids. Curr Opin Complement Alternat Med 2014, 1:e00011.
51. Xu Y., Ku B., Cui L., et al. Curcumin reverses impaired hippocampal neurogenesis and increases serotonin receptor 1A mRNA and brain-derived neurotrophic factor expression in chronically stressed rats. Brain Res 2007, 1162:9-18.
52. Ghandchi S., Jamzad M. Total flavonoids contents and anti bacterial activity of the extracts of two Labiateae species: Nepeta menthoides and Thymus trautvetteri. J Med Plants By Products 2015, 4:77-82.
53. Kraujalis P, Venskutonis PR, Ragazinskiene O. Antioxidant activities and phenolic composition of extracts from Nepeta plant species. FOODBALT-2011. 2011:79.
54. Tedeschini E., Fava M., Papakostas G.I. Placebo-controlled, antidepressant clinical trials cannot be shortened to less than 4 weeks' duration: a pooled analysis of randomized clinical trials employing a diagnostic odds ratio-based approach. J Clin Psychiatry 2011, 72:98-113.
55. Kumar G.P., Khanum F. Neuroprotective potential of phytochemicals. Pharmacogn Rev 2012, 6:81.
56. Naghibi F., Mosaddegh M., Mohammadi Motamed M., Ghorbani A. Labiatae family in folk medicine in Iran: from ethnobotany to pharmacology. Iran J Pharm Res 2010, 6:3-79.
57. Hu X.H., Bull S.A., Hunkeler E.M., et al. Incidence and duration of side effects and those rated as bothersome with selective serotonin reuptake inhibitor treatment for depression: patient report versus physician estimate. Journal Clin Psychiatry 2004, 65(1):478-965.
58. Spijker J., Nolen W. An algorithm for the pharmacological treatment of depression. Acta Psychiatr Scand 2010, 121:180-189.
59. Marcus S.C., Olfson M. National trends in the treatment for depression from 1998 to 2007. Arch Gen Psychiatry 2010, 67:1265-1273.